Stargardt’s Disease

Stargardt’s Disease
Stargardt’s Disease

Stargardt’s disease is a genetic eye condition that causes central vision loss. The condition affects the macula, which is the central part of the retina. The retina is the light sensitive film at the back of the eye. The macula is responsible for central detailed vision.

Stargardt’s most often starts to affect someone’s vision in childhood or their teenage years. Some people are diagnosed in early adulthood and less commonly later adulthood.

The symptoms and disease progression vary widely from person to person, even among affected members of the same family. The condition affects both eyes to a similar degree and typically causes slowly progressive loss of central vision with peripheral (side) vision remaining stable. Less commonly, there can be a more severe course of the condition with loss of both central and peripheral vision.

People with Stargardt’s might notice blurriness or grey/black patches in the centre of their vision. The reduction in central vision makes it very difficult to read, write and recognise faces. Problems with glare and difficulties adapting to changing light conditions are common. Colour perception can also be affected.

Stargardt’s disease is a rare condition affecting approximately 1 in 8,000-10,000 people worldwide. There are about 6000 people in the UK with Stargardt’s.

Contact other families affected by Stargardt’s Disease


The diagnosis of Stargardt’s disease often requires a number of tests and examinations. These include an Ophthalmologist examining the back of the eyes, visual acuity, visual field and colour vision tests. Different methods are used to take images of the retina including fundus autofluorescence (FAF) to see the structure of the retina and optical coherence tomography (OCT) which looks at the layers of the retina. An electroretinogram (ERG) assesses retinal function.

Genetic testing can also now help to clarify the diagnosis, although testing does not yet identify the genetic cause of the condition in all cases (2017).


Children with Stargardt’s disease should have an annual review by an Ophthalmologist. Adults with the condition are often discharged as there is no treatment, but seeing an Ophthalmologist about every 5 years for a general check-up and update on what is known about the condition is reasonable. Regular general eye checks with an optician are advisable for everyone, including people with Stargardt’s.

Management is focussed on maximising existing vision using aids and techniques. Low Vision clinics can provide optical aids, such as, magnifiers and monoculars. Many people with Stargardt’s read large bold print. Assistive technology including electronic magnifiers and magnification and text to speech computer software can also be helpful.

Social services can offer certain home adaptations and practical mobility training.

Some evidence suggests that people with Stargardt’s should avoid taking extra vitamin A in supplements. Wearing UV blocking sunglasses outdoors is also recommended.

Treatment and Research

Unfortunately, at the present time there is no cure or treatment for Stargardt’s disease (2017). There is a lot of research which is ongoing. Three main avenues of potential intervention are being explored - gene, stem cell and drug therapy.

Genetics and Inheritance

The most common form of Stargardt’s disease, Stargardt 1 (STGD1), is caused by genetic changes (mutations) in a gene called ABCA4 on chromosome 1. This gene provides the instruction for an adenosine triphosphate (ATP)-binding cassette transporter found in the light-sensing (photoreceptor) cells of the retina. Genetic changes in the ABCA4 gene cause defects in the function of this transporter resulting in the accumulation of toxic waste products (lipofuscin pigments) which over time cause retinal cell death.

Stargardt 1 is passed on in families in an autosomal recessive pattern. This means that someone with the condition will have two changed copies of the ABCA4 gene. They will have inherited one changed copy from their mother and the other from their father. Someone with one changed and one working copy of the ABCA4 gene is a carrier of Stargardt 1. Carriers do not have symptoms of the condition.

Each full sibling of someone with Stargardt 1 has a 1 in 4 or 25% chance of inheriting the condition. This chance is the same for males and females. 

When someone with Stargardt 1 has children with an unrelated partner there is about a 1 in 100 or 1% chance of them inheriting the condition.

Less commonly people can have a disorder that looks like Stargardt’s but it is due to a different gene. Other known genes include the ELOVL4 gene (causing STGD3), PROM1 gene (causing STGD4) and RDS gene (also known as PRPH2). NB. The disorder originally suggested to be STGD2 was subsequently found to be caused by the same gene as STGD3.

Stargardt’s caused by changes in the ELOVL4, PROM1 and RDS genes is inherited in an autosomal dominant pattern, which is different from that described above. For more information on dominant inheritance visit:

Genetic Services and Testing

Genetic testing methods change over time. A genetic professional from an NHS genetic clinic can arrange genetic testing, where needed, and review the inheritance pattern. Families are welcome to seek advice from genetic clinics at various times of life. For example, when an individual with Stargardt's disease or their siblings want more details as they get older, they could ask about the condition for themselves.

Contact other families affected by Stargardt’s Disease

We will try to put you in touch with other families affected by Stargardt’s Disease. Fill in the form below and a member of our support team will get back to you within 7 working days.

About you
Your message
Share this page

Welcome to the GDUK network

If this is the first time you have searched for information on a particular condition, details you find here may be distressing.

» If you would rather read our Newly Diagnosed section for parents and carers first click here